April 2018, Biomerics and ATL Technology entered into an agreement under which together they acquired the assets of Catheter Research Inc. (CRI) in both the Indianapolis and Costa Rica divisions.
Under this new Joint Venture, Biomerics will continue to deliver on its strategy to expand and invest in additional production and engineering capabilities to develop a global competitive advantage. This will enable us to complement our current portfolio and broaden our product offerings, increase our manufacturing locations and enhance the types of technology we use.
Photos of the manufacturing facility in Cartago, Costa Rica
The Biomerics-ATL joint venture has developed a new website that will provide updates to customers and interested parties, as well as additional details of this joint venture. To view the new site, please click on the button below.
We look forward to serving our customers and continuing our commitment to quality.